• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓增殖性肿瘤在慢性期和疾病进展过程中的基因组完整性。

Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression.

机构信息

Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

出版信息

Blood. 2011 Jul 7;118(1):167-76. doi: 10.1182/blood-2011-01-331678. Epub 2011 Apr 29.

DOI:10.1182/blood-2011-01-331678
PMID:21531982
Abstract

Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) are clonal myeloid disorders with increased production of terminally differentiated cells. The disease course is generally chronic, but some patients show disease progression (secondary myelofibrosis or accelerated phase) and/or leukemic transformation. We investigated chromosomal aberrations in 408 MPN samples using high-resolution single-nucleotide polymorphism microarrays to identify disease-associated somatic lesions. Of 408 samples, 37.5% had a wild-type karyotype and 62.5% harbored at least 1 chromosomal aberration. We identified 25 recurrent aberrations that were found in 3 or more samples. An increased number of chromosomal lesions was significantly associated with patient age, as well as with disease progression and leukemic transformation, but no association was observed with MPN subtypes, Janus kinase 2 (JAK2) mutational status, or disease duration. Aberrations of chromosomes 1q and 9p were positively associated with disease progression to secondary myelofibrosis or accelerated phase. Changes of chromosomes 1q, 7q, 5q, 6p, 7p, 19q, 22q, and 3q were positively associated with post-MPN acute myeloid leukemia. We mapped commonly affected regions to single target genes on chromosomes 3p (forkhead box P1 [FOXP1]), 4q (tet oncogene family member 2 [TET2]), 7p (IKAROS family zinc finger 1 [IKZF1]), 7q (cut-like homeobox 1 [CUX1]), 12p (ets variant 6 [ETV6]), and 21q (runt-related transcription factor 1 [RUNX1]). Our data provide insight into the genetic complexity of MPNs and implicate new genes involved in disease progression.

摘要

费城染色体阴性骨髓增殖性肿瘤(MPN)是一种克隆性髓系疾病,其特征是终末分化细胞的过度生成。该疾病的病程通常是慢性的,但有些患者会出现疾病进展(继发性骨髓纤维化或加速期)和/或白血病转化。我们使用高分辨率单核苷酸多态性微阵列分析了 408 例 MPN 样本中的染色体异常,以鉴定与疾病相关的体细胞病变。在 408 例样本中,37.5%为野生型核型,62.5%至少存在 1 种染色体异常。我们鉴定出 25 种反复出现的异常,这些异常在 3 个或更多样本中均有发现。染色体病变数量的增加与患者年龄以及疾病进展和白血病转化显著相关,但与 MPN 亚型、Janus 激酶 2(JAK2)突变状态或疾病持续时间无关。染色体 1q 和 9p 的异常与继发性骨髓纤维化或加速期的疾病进展呈正相关。染色体 1q、7q、5q、6p、7p、19q、22q 和 3q 的改变与骨髓增生异常后急性髓系白血病呈正相关。我们将常见的受影响区域映射到染色体 3p(叉头框 P1 [FOXP1])、4q(四联体基因家族成员 2 [TET2])、7p(IKAROS 家族锌指 1 [IKZF1])、7q(剪切样同源盒 1 [CUX1])、12p(ets 变体 6 [ETV6])和 21q( runt 相关转录因子 1 [RUNX1])上的单个靶基因。我们的数据提供了对 MPN 遗传复杂性的深入了解,并暗示了新的基因参与了疾病的进展。

相似文献

1
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression.骨髓增殖性肿瘤在慢性期和疾病进展过程中的基因组完整性。
Blood. 2011 Jul 7;118(1):167-76. doi: 10.1182/blood-2011-01-331678. Epub 2011 Apr 29.
2
Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.慢性期以及疾病进展过程中骨髓增殖性肿瘤和骨髓增生异常/骨髓增殖性肿瘤的基因组畸变。
Int J Lab Hematol. 2015 Apr;37(2):181-9. doi: 10.1111/ijlh.12257. Epub 2014 May 21.
3
Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm.通过高分辨率 SNP 阵列分析鉴定与骨髓增殖性肿瘤疾病转化相关的基因组异常。
Am J Hematol. 2011 Dec;86(12):974-9. doi: 10.1002/ajh.22166. Epub 2011 Sep 22.
4
Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.转录因子 Ikaros 在骨髓增殖性肿瘤中的缺失。
Leukemia. 2010 Jul;24(7):1290-8. doi: 10.1038/leu.2010.99. Epub 2010 May 27.
5
Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.费城染色体阴性骨髓增殖性肿瘤的临床表现及并发症危险因素
Asian Pac J Cancer Prev. 2015;16(12):5013-8. doi: 10.7314/apjcp.2015.16.12.5013.
6
Chromosomal abnormalities in transformed Ph-negative myeloproliferative neoplasms are associated to the transformation subtype and independent of JAK2 and the TET2 mutations.转化型 Ph 阴性骨髓增殖性肿瘤中的染色体异常与转化亚型相关,且独立于 JAK2 和 TET2 突变。
Genes Chromosomes Cancer. 2010 Oct;49(10):919-27. doi: 10.1002/gcc.20802.
7
Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms.伴有费城染色体阴性骨髓增殖性肿瘤向白血病转化的等位基因失衡的流行率及其对预后的影响。
Blood. 2010 Apr 8;115(14):2882-90. doi: 10.1182/blood-2009-07-235119. Epub 2010 Jan 12.
8
Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications.费城染色体阴性慢性骨髓增殖性疾病的细胞遗传学和分子学特征:临床意义
Cancer Lett. 2007 Sep 18;255(1):12-25. doi: 10.1016/j.canlet.2007.02.009. Epub 2007 Mar 23.
9
Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia.与骨髓增生性肿瘤向急性髓系白血病转化相关的 Janus 激酶 2 变异体。
Cancer. 2019 Jun 1;125(11):1855-1866. doi: 10.1002/cncr.31986. Epub 2019 Feb 27.
10
Association of TNF polymorphisms with JAK2 (V617F) myeloproliferative neoplasms in Brazilian patients.巴西患者中TNF基因多态性与JAK2(V617F)骨髓增殖性肿瘤的关联。
Blood Cells Mol Dis. 2016 Mar;57:54-7. doi: 10.1016/j.bcmd.2015.12.005. Epub 2015 Dec 10.

引用本文的文献

1
Impact of ETV6 mutations on clinical outcomes in acute myeloid leukemia: a real-world retrospective cohort study.ETV6突变对急性髓系白血病临床结局的影响:一项真实世界回顾性队列研究。
Ann Hematol. 2025 Jun 21. doi: 10.1007/s00277-025-06451-6.
2
Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1A.染色体碎裂相关的21号染色体扩增通过可靶向的DYRK1A过表达调控向急变期骨髓增殖性肿瘤的转化。
Nat Genet. 2025 Jun;57(6):1478-1492. doi: 10.1038/s41588-025-02190-6. Epub 2025 Jun 9.
3
Whole-genome sequencing of myeloproliferative neoplasms revealed dynamic clonal changes in the fibrotic or leukemic transformation and novel FOXP1 mutations in the fibrotic transformation.
骨髓增殖性肿瘤的全基因组测序揭示了纤维化或白血病转化过程中的动态克隆变化以及纤维化转化中的新型FOXP1突变。
Leukemia. 2025 May;39(5):1218-1227. doi: 10.1038/s41375-025-02576-9. Epub 2025 Mar 31.
4
Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of JAK2-mutated post-MPN AML.新型BCL-xL降解剂DT2216在JAK2突变的骨髓增殖性肿瘤后急性髓系白血病临床前模型中的疗效
Blood. 2025 Jul 17;146(3):341-355. doi: 10.1182/blood.2024027117.
5
High Mobility Group A1 Chromatin Keys: Unlocking the Genome During MPN Progression.高迁移率族蛋白A1染色质关键因子:在骨髓增殖性肿瘤进展过程中解锁基因组
Int J Mol Sci. 2025 Feb 27;26(5):2125. doi: 10.3390/ijms26052125.
6
Cas9-directed long-read sequencing to resolve optical genome mapping findings in leukemia diagnostics.利用 Cas9 指导的长读测序解决白血病诊断中光学基因组图谱的发现。
Sci Rep. 2024 Apr 12;14(1):8508. doi: 10.1038/s41598-024-59092-6.
7
Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms.钙网蛋白和JAK2V617F驱动突变在骨髓增殖性肿瘤中诱导不同的有丝分裂缺陷。
Sci Rep. 2024 Feb 2;14(1):2810. doi: 10.1038/s41598-024-53240-8.
8
STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient.STAT5a和SH2B3新突变在一名三阴性原发性骨髓纤维化患者中显示出恶性作用。
Cancer Gene Ther. 2024 Mar;31(3):484-494. doi: 10.1038/s41417-023-00719-7. Epub 2023 Dec 22.
9
Shared and distinct genetic etiologies for different types of clonal hematopoiesis.不同类型克隆性造血的共享和独特的遗传病因。
Nat Commun. 2023 Sep 8;14(1):5536. doi: 10.1038/s41467-023-41315-5.
10
Treating accelerated and blast phase myeloproliferative neoplasms: progress and challenges.治疗加速期和急变期骨髓增殖性肿瘤:进展与挑战
Ther Adv Hematol. 2023 Jun 22;14:20406207231177282. doi: 10.1177/20406207231177282. eCollection 2023.